94 related articles for article (PubMed ID: 6687560)
41. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
Valdivieso M; Stroehlein JR; Bedikian AY; Karlin DA; Legha SS; Bennetts RW; Bodey GP
Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
[TBL] [Abstract][Full Text] [Related]
42. Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
Kramer BS; Birch R; Einhorn L; Greco A
Cancer Treat Rep; 1985 Mar; 69(3):333-4. PubMed ID: 2983895
[No Abstract] [Full Text] [Related]
43. Phase I study of m-AMSA in patients with solid tumors and leukemias.
Goldsmith MA; Bhardwaj S; Ohnuma T; Greenspan EM; Holland JF
Cancer Clin Trials; 1980; 3(3):197-202. PubMed ID: 6893683
[TBL] [Abstract][Full Text] [Related]
44. Phase I-II study of m-AMSA administered as a continuous infusion.
Micetich KC; Zwelling LA; Gormley P; Young RC
Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
[TBL] [Abstract][Full Text] [Related]
45. Phase II Study of AMSA, prednisone, and chlorambucil (APC) in the treatment of refractory breast cancer: a Northern California Oncology Group Study.
Friedman MA; Marcus F; Kohler M; Resser KJ
Cancer Treat Rep; 1982 May; 66(5):1235-6. PubMed ID: 7083225
[No Abstract] [Full Text] [Related]
46. Progress in the management of testicular germ-cell tumours.
Oliver RT
Practitioner; 1982 Nov; 226(1373):1903-15. PubMed ID: 6891458
[No Abstract] [Full Text] [Related]
47. Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.
De Jager R; Siegenthaler P; Cavalli F; Klepp O; Bramwell V; Joss R; Alberto P; van Glabbeke M; Renard J; Rozencweig M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):289-93. PubMed ID: 6687457
[TBL] [Abstract][Full Text] [Related]
48. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.
Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR
Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864
[TBL] [Abstract][Full Text] [Related]
49. Phase II study of m-AMSA in advances malignant melanoma.
Arseneau JC; Wolter JM; Probert JC; Kuperminc M
Am J Clin Oncol; 1982 Aug; 5(4):433-6. PubMed ID: 6896795
[TBL] [Abstract][Full Text] [Related]
50. AMSA therapy for children with lymphoblastic malignancy.
Hutter JJ; Meyskens FL
Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
[No Abstract] [Full Text] [Related]
51. Pilot studies of various combinations of dibromodulcitol, VP-16, and AMSA.
Eagan RT
Oncology; 1982; 39(5):295-7. PubMed ID: 6896559
[TBL] [Abstract][Full Text] [Related]
52. Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma.
Fuks JZ; Van Echo DA; Aisner J; Schipper H; Levitt M; Wiernik PH
Cancer Treat Rep; 1982 May; 66(5):1237-8. PubMed ID: 7083226
[No Abstract] [Full Text] [Related]
53. Trial of AMSA in acute leukemia.
Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
[No Abstract] [Full Text] [Related]
54. Phase II study of amsacrine in metastatic renal cell carcinoma: a Cancer and Leukemia Group B study.
Amrein PC; Coleman M; Richards F; Poulin RF; Berkowitz I; Kennedy BJ; Green M; Herschkopf R; Rafla S
Cancer Treat Rep; 1983 Nov; 67(11):1043-4. PubMed ID: 6688967
[No Abstract] [Full Text] [Related]
55. Pediatric oncology group phase II trial of amsacrine in children with solid tumors.
Civin CI; Krischer JP; Land VJ; Nitschke R; Kamen B; Vats T
Cancer Treat Rep; 1985 Mar; 69(3):335-6. PubMed ID: 3838498
[No Abstract] [Full Text] [Related]
56. Phase II trial of amsacrine in children with advanced metastatic neuroblastoma.
De Bernardi B; Pastore G; Garaventa A; Calculli G; Carli M; Ceci A; di Montezemolo LC; Pianca C; Romano C; Russo A
Cancer Treat Rep; 1984; 68(7-8):1051-2. PubMed ID: 6547640
[No Abstract] [Full Text] [Related]
57. Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma.
Greco C; Zupi G; Badaracco G
Cancer Chemother Pharmacol; 1983; 11(1):38-42. PubMed ID: 6688382
[TBL] [Abstract][Full Text] [Related]
58. [Phase II study on cis-diamminedichloroplatinum (II) by a collaborative study].
Gan To Kagaku Ryoho; 1982 Jan; 9(1):46-54. PubMed ID: 6892191
[TBL] [Abstract][Full Text] [Related]
59. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
[TBL] [Abstract][Full Text] [Related]
60. AMSA--a promising new agent in refractory acute leukemia.
Lawrence HJ; Ries CA; Reynolds RD; Lewis JP; Koretz MM; Torti FM
Cancer Treat Rep; 1982 Jul; 66(7):1475-8. PubMed ID: 7046928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]